Paulson & Co Portfolio

In its Q2 2026 13F filing, Paulson & Co disclosed 8 equity positions with a combined reported value of $2.58B. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were MDGL ($719.52M), PPTA ($671.53M), AAMI ($417.91M). By sector, the heaviest allocations are Health Care 42.0%, Materials 40.5%. Versus the prior quarter, allocation shifted toward Health Care (+5.8pp), Financials (+2.7pp) and away from Materials (-9.1pp).

Versus the prior quarter, Paulson & Co opened 1 new positions, trimmed 2 and fully exited 2, a turnover rate of 50.0% of positions. The portfolio's overlap with the prior quarter was 70% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.